8.900
+0,00%
2026-10-19
Fundamental Analysis
67 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +20.9% | +40.0% | 3 / 3 | +19.0% | +1.00 pp | +0.13 pp | +7.2% | 0.00 | 10.05 | 3.535 | +19,0% | 292 | +20,9% | 10.05 | 15.12 | −33,5% |
| Pts | 4 | 8 | 12 | 8 | 8 | 8 | 0 | 12 | 12 | |||||||
Valuation annotation:Price: 8.900 (close price on 2026-10-19)EPS (TTM): 885,8
Financial charts
1.Revenue & growth
VND bn3.535Q2/26
1.Revenue & growth
VND bn3.535Q2/26
2.Profit & growth
VND bn292Q2/26
3.Profit mix (Penman)
VND bn566Q2/26
4.Margins & cost structure
%6.0%Q2/26
5.Returns & cash cycle
% · days7.4%Q2/26
6.Earnings quality & cash
VND bn966Q2/26
7.Asset structure
VND bn7.582Q2/26
8.Funding & debt health
VND bn · times7.582Q2/26
9.Revenue backlog
VND bn0,05Q2/26
10.Valuation
times · %10,0×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %584Q2/26
Adjusted EPS growth, latest quarter
20.9%
Average adjusted EPS growth, 3 quarters
25.5%
averaged over 2 quarter(s)
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26